跳至主要内容
临床试验/NCT02025894
NCT02025894已完成不适用

Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study

Institut de Cancérologie de la Loire27 个研究点 分布在 1 个国家目标入组 3,032 人开始时间: 2010年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
3,032
试验地点
27
主要终点
Thromboembolic complications:

研究概览

简要总结

The purpose of this study is to identify risk factors for thromboembolic and /or infectious complications in 3,000 patients with solid tumor and receiving a Percutaneous Central Venous Catheter (PCVC). A better understanding of the risk factors for these complications in this population would then allow interventional studies to be proposed to assess the benefit of prophylactic procedures in a sub-group of patients at most risk.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with a neoplastic solid tumour with an indication for insertion of a PCVC.

排除标准

  • Haematological neoplasm pathology, PCVC removal scheduled within 2 weeks of insertion,
  • Therapeutic doses of anticoagulants required at inclusion,
  • PCVC inserted by the femoral vein

结局指标

主要结局

Thromboembolic complications:

时间窗: one year

Locoregional or disseminated infectious complications:

时间窗: one year

次要结局

  • Medical and economic consequences of these complications(one year)

研究者

发起方
Institut de Cancérologie de la Loire
申办方类型
Other
责任方
Sponsor

研究点 (27)

Loading locations...

相似试验